RAMB - JULHO 2017

13 / 113

Guidelines for the treatment of central nervous system metastases using radiosurgery
Rev Assoc Med B ras 2017; 63(7):559-563 563
17. Luther N, Kondziolka D, Kano H, Mousavi SH, Flickinger JC, Lunsford LD.
Motor function after stereotactic radiosurgery for brain metastases in the
region of the motor cortex. J Neurosurg. 2013; 119(3):683-8.
18. Şengöz M, Kabalay IA, Tezcanlı E, Peker S, Pamir N. Treatment of brainstem
metastases with gamma-knife radiosurgery. J Neurooncol. 2013; 113(1):33-8.
19. Peterson HE, Larson EW, Fairbanks RK, MacKay AR, Lamoreaux WT, Call
JA, et al. Gamma knife treatment of brainstem metastases. Int J Mol Sci.
2014; 15(6):9748-61.
20. Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC,
et al. Whole brain radiation therapy with or without stereotactic radiosurgery
boost for patients with one to three brain metastases: phase III results of
the RTOG 9508 randomised trial. Lancet. 2004; 363(9422):1665-72.
21. Kondziolka D, Patel A, Lunsford LD, Kassam A, Flickinger JC. Stereotactic
radiosurgery plus whole brain radiotherapy versus radiotherapy alone for
patients with multiple brain metastases. Int J Radiat Oncol Biol Phys. 1999;
45(2):427-34.
22. Mehta MP, Tsao MN, Whelan TJ, Morris DE, Hayman JA, Flickinger JC, et
al. The American Society for Therapeutic Radiology and Oncology (ASTRO)
evidence-based review of the role of radiosurgery for brain metastases. Int
J Radiat Oncol Biol Phys. 2005; 63(1):37-46.
23. Shaw E, Scott C, Souhami L, Dinapoli R, Kline R, Loeffler J, et al. Single
dose radiosurgical treatment of recurrent previously irradiated primary
brain tumors and brain metastases: final report of RTOG protocol 90-05.
Int J Radiat Oncol Biol Phys. 2000; 47(2):291-8.
24. Knisely JP, Yamamoto M, Gross CP, Castrucci WA, Jokura H, Chiang VL.
Radiosurgery alone for 5 or more brain metastases: expert opinion survey.
J Neurosurg. 2010; 113 Suppl:84-9.
25. Rava P, Leonard K, Sioshansi S, Curran B, Wazer DE, Cosgrove GR, et al.
Survival among patients with 10 or more brain metastases treated with
stereotactic radiosurgery. J Neurosurg. 2013; 119(2):457-62.
26. Bhatnagar AK, Flickinger JC, Kondziolka D, Lunsford LD. Stereotactic
radiosurgery for four or more intracranial metastases. Int J Radiat Oncol
Biol Phys. 2006; 64(3):898-903.
27. Skeie BS, Skeie GO, Enger PØ, Ganz JC, Heggdal JI, Ystevik B, et al. Gamma
knife surgery in brain melanomas: absence of extracranial metastases and
tumor volume strongest indicators of prolonged survival. World Neurosurg.
2011; 75(5-6):684-91; discussion 598-603.
28. Xue J, Kubicek GJ, Grimm J, LaCouture T, Chen Y, Goldman HW, et al.
Biological implications of whole brain radiotherapy versus stereotactic
radiosurgery of multiple brain metastases. J Neurosurg. 2014; 121 Suppl:60-8.
29. Aoyama H, Shirato H, Tago M, Nakagawa K, Toyoda T, Hatano K, et al.
Stereotactic radiosurgery plus whole brain radiation therapy vs stereotactic
radiosurgery alone for treatment of brain metastases: a randomized controlled
trial. JAMA. 2006; 295(21):2483-91.
30. Chang EL, Wefel JS, Hess KR, Allen PK, Lang FF, Kornguth DG, et al.
Neurocognition in patients with brain metastases treated with radiosurgery
or radiosurgery plus whole brain irradiation: a randomised controlled trial.
Lancet Oncol. 2009; 10(11):1037-44.
31. Tsao M, Xu W, Sahgal A. A meta-analysis evaluating stereotactic radiosurgery,
whole brain radiotherapy, or both for patients presenting with a limited
number of brain metastases. Cancer. 2012; 118(9):2486-93.
32. Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, et
al. A European Organisation for Research and Treatment of Cancer phase
III trial of adjuvant whole brain radiotherapy versus observation in patients
with one to three brain metastases from solid tumors after surgical resection
or radiosurgery: quality-of-life results. J Clin Oncol. 2013; 31(1):65-72.
33. Sun A, Bae K, Gore EM, Movsas B, Wong SJ, Meyers CA, et al. Phase III trial
of prophylactic cranial irradiation compared with observation in patients
with locally advanced non-small-cell lung cancer: neurocognitive and quality-
of-life analysis. J Clin Oncol. 2011; 29(3):279-86.
34. Gondi V, Paulus R, Bruner DW, Meyers CA, Gore EM, Wolfson A, et al.
Decline in tested and self-reported cognitive functioning after prophylactic
cranial irradiation for lung cancer: pooled secondary analysis of Radiation
Therapy Oncology Group randomized trials 0212 and 0214. Int J Radiat
Oncol Biol Phys. 2013; 86(4):656-64.
35. Meyners T, Heisterkamp C, Kueter JD, Veninga T, Stalpers LJ, Schild SE, et
al. Prognostic factors for outcomes after whole brain irradiation of brain
metastases from relatively radioresistant tumors: a retrospective analysis.
BMC Cancer. 2010; 10:582.
36. Seastone DJ, Elson P, Garcia JA, Chao ST, Suh JH, Angelov L, et al. Clinical
outcome of stereotactic radiosurgery for central nervous systemmetastases
from renal cell carcinoma. Clin Genitourin Cancer. 2014; 12(2):111-6.
37. Alexander E 3rd, Moriarty TM, Davis RB, Wen PY, Fine HA, Black PM, et al.
Stereotactic radiosurgery for the definitive, noninvasive treatment of brain
metastases. J Natl Cancer Inst. 1995; 87(1):34-40.
38. Pirzkall A, Debus J, Lohr F, Fuss M, Rhein B, Engenhart-Cabillic R, et al.
Radiosurgery alone or in combination with whole brain radiotherapy for
brain metastases. J Clin Oncol. 1998; 16(11):3563-9.
39. Schomas DA, Roeske JC, MacDonald RL, Sweeney PJ, Mehta N, Mundt AJ. Pre-
dictors of tumor control in patients treated with linac-based stereotactic radio-
surgery for metastatic disease to the brain. Am J Clin Oncol. 2005; 28(2):180-7.
40. Rodrigues G, Zindler J, Warner A, Lagerwaard F. Recursive partitioning
analysis for the prediction of stereotactic radiosurgery brain metastases
lesion control. Oncologist. 2013; 18(3):330-5.
41. Shuto T, Inomori S, Fujino H, Nagano H. Gamma knife surgery for metastatic
brain tumors from renal cell carcinoma. J Neurosurg. 2006; 105(4):555-60.
42. Auchter RM, Lamond JP, Alexander E, Buatti JM, Chappell R, Friedman WA,
et al. A multiinstitutional outcome and prognostic factor analysis of radio-
surgery for resectable single brain metastasis. Int J Radiat Oncol Biol Phys.
1996; 35(1):27-35.
43. Wowra B, Siebels M, Muacevic A, Kreth FW, Mack A, Hofstetter A. Repeated
gamma knife surgery for multiple brain metastases from renal cell carcinoma.
J Neurosurg. 2002; 97(4):785-93.
44. Brown PD, Asher AL, Ballman KV, Farace E, Cerhan JH, et al. NCCTG N0574
(Alliance): a phase III randomized trial of whole brain radiation therapy
(WBRT) in addition to radiosurgery (SRS) in patients with 1 to 3 brain
metastases. J Clin Oncol. 2015; 33(15 suppl; abstr LBA4).
45. Sahgal A, Aoyama H, Kocher M, Neupane B, Collette S, Tago M, et al. Phase
3 trials of stereotactic radiosurgery with or without whole brain radiation
therapy for 1 to 4 brain metastases: individual patient data meta-analysis.
Int J Radiat Oncol Biol Phys. 2015; 91(4):710-7.
46. Hall MD, McGee JL, McGee MC, Hall KA, Neils DM, Klopfenstein JD, et al.
Cost-effectiveness of stereotactic radiosurgery with and without whole brain
radiotherapy for the treatment of newly diagnosed brain metastases. J
Neurosurg. 2014; 121 Suppl:84-90.
47. Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, et
al. A randomized trial of surgery in the treatment of single metastases to
the brain. N Engl J Med. 1990; 322(8):494-500.
48. Noordijk EM, Vecht CJ, Haaxma-Reiche H, Padberg GW, Voormolen JH,
Hoekstra FH, et al. The choice of treatment of single brain metastasis should
be based on extracranial tumor activity and age. Int J Radiat Oncol Biol
Phys. 1994; 29(4):711-7.
49. Brennan C, Yang TJ, Hilden P, Zhang Z, Chan K, Yamada Y, et al. A phase
2 trial of stereotactic radiosurgery boost after surgical resection for brain
metastases. Int J Radiat Oncol Biol Phys. 2014; 88(1):130-6.
50. Mathieu D, Kondziolka D, Flickinger JC, Fortin D, Kenny B, Michaud K, et
al. Tumor bed radiosurgery after resection of cerebral metastases.
Neurosurgery. 2008; 62(4):817-23; discussion 823-4.
51. Hartford AC, Paravati AJ, Spire WJ, Li Z, Jarvis LA, Fadul CE, et al.
Postoperative stereotactic radiosurgery without whole brain radiation
therapy for brain metastases: potential role of preoperative tumor size. Int
J Radiat Oncol Biol Phys. 2013; 85(3):650-5.
52. Do L, Pezner R, Radany E, Liu A, Staud C, Badie B. Resection followed by
stereotactic radiosurgery to resection cavity for intracranial metastases. Int
J Radiat Oncol Biol Phys. 2009; 73(2):486-91.
53. Soltys SG, Adler JR, Lipani JD, Jackson PS, Choi CY, Puataweepong P, et al.
Stereotactic radiosurgery of the postoperative resection cavity for brain
metastases. Int J Radiat Oncol Biol Phys. 2008; 70(1):187-93.
54. Minniti G, Esposito V, Clarke E, Scaringi C, Lanzetta G, Salvati M, et al. Mul-
tidose stereotactic radiosurgery (9 Gy x 3) of the postoperative resection ca-
vity for treatment of large brain metastases. Int J Radiat Oncol Biol Phys.
2013; 86(4):623-9.
55. Rao G, Ahmed S, Hess K, Mahajan A. Postoperative Stereotactic Radiosurgery
vs Observation for Completely Resected Brain Metastases: Results of a
Prospective Randomized Study. Neurosurgery. 2016; 63 Suppl 1:184.
56. Kayama T, Sato S, Sakurada K, Mizusawa J, Nishikawa R, Narita Y et al.
JCOG0504: A phase III randomized trial of surgery with whole brain radiation
therapy versus surgery with salvage stereotactic radiosurgery in patients
with 1 to 4 brain metastases. Available on:
record/125226/abstract.
57. Brown PD, Ballman KV, Cerhan J, Anderson SK, Carrero XW, Whitton AC et
al. N107C/CEC.3: A Phase III Trial of Post-Operative Stereotactic Radiosurgery
(SRS) Compared with Whole Brain Radiotherapy (WBRT) for Resected
Metastatic Brain Disease. Int J Radiat Oncol Biol Phys. 2016; 96(5):937.